MediRemindADHD Medication Management App · Australia

ADHD Medication Management App for Australians

Remember doses, keep eScripts easy to find and track repeats before you run low.

MediRemind is an ADHD medication app for Australians and an ADHD reminder app for keeping doses, eScripts, paper prescriptions, repeats and recorded expiry dates organised. It is a practical app for ADHD medication management, not a clinical tool or substitute for your prescriber or pharmacist.

  • Repeat and recorded expiry tracking
  • eScripts and paper scripts
  • Expiry date reminders
  • Separate child profiles, manage your child's script without sharing your account

30-day trial, then a subscription · $4.99/month or $39.99/year

Download on the App StoreGet it on Google Play
Scan with your phone
MediRemind app showing ADHD medication schedule, Vyvanse, Dexamfetamine and Clonidine with reminders and repeat tracking

iPhone and Android

What MediRemind does, and does not do

MediRemind organises medications, prescription records, repeat information and reminders. It does not diagnose ADHD, calculate doses, recommend treatments or replace advice from your prescriber or pharmacist. The expiry reminder is based on the date you enter. MediRemind does not independently determine whether a prescription is still legally valid.

Why ADHD medication can be difficult to manage

Around one in 20 Australians lives with ADHD. Use of ADHD medicines has grown rapidly: the population rate receiving PBS-listed ADHD medicines increased from 11 people per 1,000 in 2020–21 to 22 per 1,000 in 2023–24.

ADHD can make future tasks harder to remember and initiate, including taking medication, finding an eScript, checking remaining repeats or arranging a new prescription before the current supply runs out. Adherence can also be affected by side effects, treatment preferences, cost, supply and daily routines. It is rarely one single cause.

None of this is a discipline problem. It reflects the practical reality that ADHD medication management requires several tasks to happen at the right time, and that is an organisational problem an app can genuinely help with.

MediRemind helps Australian patients organise ADHD medications, eScripts, paper prescriptions, reminders and remaining repeats on their phone.

The four things you need to track

Miss any one of these and the result is the same, a gap in medication:

Dose schedule

What to take, and when, morning only, twice daily, or as prescribed.

The eScript or paper prescription itself

Where it actually is, not buried in a six-week-old SMS or lost on the kitchen bench.

Remaining repeats

How many dispensings are left on the prescription, especially important for Schedule 8 prescriptions, which commonly have shorter validity periods than standard prescriptions.

Recorded expiry date

When the prescription runs out, MediRemind records the date you enter and reminds you before it passes.

30-day trial, then a subscription · $4.99/month or $39.99/year

ADHD prescribing rules differ across Australia

ADHD stimulant medicines such as dexamfetamine, lisdexamfetamine and methylphenidate are Schedule 8 medicines. Schedule 8 prescriptions can have shorter validity periods and additional requirements that vary between states and territories.

Who may diagnose ADHD, initiate stimulant treatment or continue an existing prescription depends on the state or territory:

New South Wales: Authorised continuation GPs can provide ongoing prescriptions to eligible patients who are stable on treatment. Trained endorsed GPs are expected to begin diagnosing and initiating treatment from September 2026.

Australian Capital Territory: Eligible GPs may continue specified stimulant treatment following specialist initiation or review. The ACT pathway commenced on 11 February 2026.

South Australia: Trained GPs may assess, diagnose and treat eligible patients, including prescribing ADHD medication. SA's trained-GP pathway commenced on 28 February 2026.

Requirements change. Confirm the current position with your prescriber, pharmacist or state health department.

Because Schedule 8 prescriptions commonly have shorter validity periods than standard scripts, keeping track of the recorded expiry date is especially important. MediRemind records the date you enter and sends a reminder before it passes, giving you time to book a GP appointment before supply runs out. See how the repeat prescription tracker works.

ADHD medicine shortages can change quickly

Last shortage information checked: 17 August 2026

Rubifen LA capsules remain affected by a shortage expected to continue until 1 September 2026. Concerta, Ritalin LA and most other methylphenidate modified-release products are currently listed as available. Shortage situations can change quickly, check the TGA Medicine Shortage Reports Database or ask your pharmacist.

During a shortage

Start looking for a refill well before your supply runs out. Do not change brands, doses or timing without advice from your prescriber or pharmacist. MediRemind's repeat counter and expiry reminder help you see exactly when you need to act, not the day you've already run out.

ADHD Medication Organisation Preview

See how your existing prescription routine could be organised in MediRemind

Enter only the directions already provided by your prescriber or shown on your pharmacy label.

Which ADHD medicines do you manage?

Frequency (as on your prescription label)

Preferred reminder time

Repeats remaining (optional)

Who is this medication for?

MediRemind does not recommend medication timing, doses or treatment. Follow your prescription label and your prescriber's instructions.

30-day trial, then a subscription · $4.99/month or $39.99/year

Managing a child's ADHD medication

Parents and carers often carry the full organisational load for a child's ADHD treatment, finding the script, counting repeats, tracking the expiry date and booking GP appointments before supply runs out, while also managing their own medications. MediRemind supports separate profiles for each family member on one device, each kept separate within the app.

Separate profiles, no shared login

A child's Vyvanse or Dexamfetamine script stays in their own profile, separate repeat count, separate reminders, separate expiry date. Switch between family members with one tap. No separate app account or pharmacy registration required for each person.

Paper or eScript, organised the same way

Whether your child's ADHD prescription arrives on paper or electronically, MediRemind stores it alongside your eScripts. Track the script, remaining repeats and recorded expiry date in the same place, whichever format the prescription arrived in.

Expiry reminders so you can book the GP in time

Schedule 8 prescriptions can have shorter validity periods that vary between states and territories. MediRemind records the expiry date you enter and sends a reminder before it passes, giving you a window to book the GP appointment before your child's supply runs out, not after.

30-day trial, then a subscription · $4.99/month or $39.99/year

Australian-owned. Your medication information stays on your device.

MediRemind is built and owned in Australia, designed around the Australian eScript and PBS system.

Medication, eScript and reminder information is stored on your device and is not sold for advertising. Information is shared only when you choose to use a feature such as Carer Share or Request Dispense. Limited account, subscription and diagnostic information may be processed to operate the app.

Frequently asked questions

Q

Can MediRemind track ADHD prescription repeats?

A

Yes. MediRemind records how many repeats remain on each prescription and the expiry date you enter or import, and reminds you before that recorded date so you can arrange a new script in time.

Q

What is the best app for managing ADHD medication in Australia?

A

MediRemind is an organisational ADHD medication app for storing eScripts and paper prescriptions, recording repeats and expiry dates, and setting reminders. It is not clinical advice or a replacement for your prescriber or pharmacist.

Q

Can I manage my child's ADHD medication separately?

A

Yes. MediRemind supports separate profiles for each family member on one device. A child's Vyvanse or Dexamfetamine script, including its repeat count, recorded expiry date and reminders, is kept completely separate from your own medications. No shared login, no separate account required.

Q

My child has a paper prescription for Vyvanse, can MediRemind track it?

A

Yes. MediRemind stores both eScripts and paper prescriptions. Whether your child's ADHD prescription arrives on paper or electronically, MediRemind keeps the prescription details, remaining repeats and recorded expiry date organised in one place.

Q

How do I get reminded before my child's ADHD prescription expires?

A

When you add your child's medication in their profile, enter the prescription expiry date. MediRemind will send a reminder before that date so you have time to book a GP appointment, important for Schedule 8 prescriptions, which can have shorter validity periods and cannot simply be renewed on the day you run out.

Q

What should I do during an ADHD medication shortage?

A

Check the TGA Medicine Shortage Reports Database or ask your pharmacist about your specific medicine and strength, and start looking for a refill well before your supply runs out. Do not change brands, doses or timing without advice from your prescriber or pharmacist.

Q

How does MediRemind's trial and subscription work?

A

MediRemind includes a 30-day trial, then a subscription applies. The subscription is $4.99/month or $39.99/year.

Q

Do ADHD stimulant prescriptions expire sooner than regular scripts?

A

Schedule 8 prescriptions can have shorter validity periods than standard prescriptions, with requirements that vary between states and territories. MediRemind lets you record the expiry date and will remind you before it passes.

Q

Is my medication information private?

A

Medication, eScript and reminder information is stored on your device and is not sold for advertising. Information is shared only when you choose to use a feature such as Carer Share or Request Dispense. Limited account, subscription and diagnostic information may be processed to operate the app.

This page is general information only and is not medical advice. Speak with your doctor, psychiatrist, paediatrician or pharmacist about your own ADHD treatment. MediRemind is a medication management app, not a clinical tool.

30-day trial, then a subscription · $4.99/month or $39.99/year

Keep the medication side of ADHD organised

30-day trial, then a subscription · $4.99/month or $39.99/year

Scan with your phone
Further Reading

Related guides